All Relations between Parkinson Disease and hippocampus
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Nicolaas I Bohnen, Satyanarayana Gedela, Priyantha Herath, Gregory M Constantine, Robert Y Moor. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neuroscience letters. vol 447. issue 1. 2009-04-14. PMID:18838108. | selective hyposmia in parkinson disease: association with hippocampal dopamine activity. | 2009-04-14 | 2023-08-12 | human |
| I Ferrer, R Blanc. N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain research. Molecular brain research. vol 77. issue 2. 2000-08-11. PMID:10837922. | the present study examines n-myc and c-myc protein expression with western blotting and single and double-labeling immunohistochemistry in the hippocampus in alzheimer disease (ad), the striatum in huntington disease (hd) and the substantia nigra in parkinson disease (pd). | 2000-08-11 | 2023-08-12 | human |
| A M Iacopino, S Christako. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proceedings of the National Academy of Sciences of the United States of America. vol 87. issue 11. 1990-07-12. PMID:2140897. | comparison of diseased human brain tissue with age- and sex-matched controls yielded significant decreases (60-88%) in calbindin protein and mrna in the substantia nigra (parkinson disease), in the corpus striatum (huntington disease), in the nucleus basalis (alzheimer disease), and in the hippocampus and nucleus raphe dorsalis (parkinson, huntington, and alzheimer diseases) but not in the cerebellum, neocortex, amygdala, or locus ceruleus. | 1990-07-12 | 2023-08-11 | human |